Aspirin, Angioplasty, and Proton Beam Therapy: The Economics of Smarter Health Care Spending - Katherine Baicker & Amitabh Chandra (2011)
Baicker and Chandra (2011) argue that the U.S. healthcare system is not just expensive, but deeply inefficient in how resources are allocated.
They show that healthcare spending has grown to a large share of GDP, yet much of it does not translate into better outcomes due to misaligned incentives and poor allocation of care.
Low-cost, highly effective treatments are often underused, while expensive and low-value procedures are overutilized. The authors distinguish between “productive inefficiency” (wasted spending) and “allocative inefficiency” (spending too much overall), arguing that reform should focus on improving value, not just reducing costs.
The U.S. healthcare problem is inefficiency—not just high spending
There are two types of inefficiency: productive vs allocative
High-value care is underused, low-value care is overused
Incentives in the system are fundamentally misaligned
Public and private insurance both contribute to inefficiency
More spending does not necessarily lead to better outcomes
The system adopts technologies in the wrong order
Reform should focus on value, not just cost-cutting
Policy solutions must target incentives
⭐ Star Facts
- U.S. healthcare spending accounts for about 16% of GDP and is projected to exceed 25% in the coming decades.
- Real healthcare spending grew from $330 billion (1966) to about $2.5 trillion (2009).
- Public healthcare spending is projected to rise from 5.5% of GDP to nearly 14%+ by 2060, putting major pressure on government finances.
- The tax subsidy for employer-sponsored insurance exceeds $250 billion annually, encouraging overconsumption of healthcare.
- Some estimates suggest the U.S. could achieve similar health outcomes with ~30% less spending if inefficiencies were reduced.
- Every $1 of public healthcare spending may carry an additional ~30 cents in economic cost due to tax distortions (deadweight loss).